Current Status of Antiplatelet Agents to Prevent Stroke
- نوع فایل : کتاب
- زبان : انگلیسی
- مؤلف : Thalia S. Field & Oscar R. Benavente
- چاپ و سال / کشور: 2010
Description
Stroke is one of the leading causes of disability; most are due to atherothrombotic mechanisms. About one third of ischemic strokes are preceded by other stroke or transient ischemic attacks. Stroke survivors are at high risk for vascular events (i.e., cerebrovascular and cardiovascular). Prevention of recurrent stroke and other major vascular events can be accomplished by control of risk factors. Nonetheless, the use of antiplatelet agents remains the fundamental component of secondary stroke prevention strategy in patients with noncardioembolic disease. Currently, the uses of aspirin, clopidogrel, or aspirin plus extended-release dipyridamole are valid alternatives for stroke or transient ischemic attack patients. To maximize the beneficial effects of these agents, the treatment should be initiated as early as possible and continue on a lifelong basis.
Curr Neurol Neurosci Rep (2011) 11:6–14 DOI 10.1007/s11910-010-0162-y Published online: 23 November 2010
